The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease

Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez M-L, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau J-M, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A & Lopez Lopez C
Choose the citation style.
Neumann, U., Ufer, M., Jacobson, L. H., Rouzade-Dominguez, M. L., Huledal, G., Kolly, C., … Lopez Lopez, C. (2018). The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease. EMBO Molecular Medicine, 10(11), e9316 (18 pp.). https://doi.org/10.15252/emmm.201809316